DTP3

Study title: A Phase I/IIa Dose Escalation, And Subsequent Cohort Expansion Study Of The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Preliminary Clinical Efficacy Of Intravenous DTP3 In Patients With Relapsed Or Refractory Multiple Myeloma.

Email: s.bannoo@imperial.ac.uk
Tel: 0203 313 4224

REC reference:15/LO/1908

DTP3